Alogliptin 12.5 mg/1
Alogliptin · TABLET, FILM COATED · Padagis Israel Pharmaceuticals Ltd
No Recall History
Plain English
Alogliptin is a tablet, film coated containing alogliptin at 12.5 mg/1, taken oral. Manufactured by Padagis Israel Pharmaceuticals Ltd.
Key Facts
- Brand Name
- Alogliptin
- Generic Name
- Alogliptin
- NDC Code (Product)
45802-103- Manufacturer
- Padagis Israel Pharmaceuticals Ltd
- Strength
- 12.5 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA022271
- Marketing Start
- 04/08/2016
Recall History
No Recall HistoryFrequently Asked Questions
What is Alogliptin used for?
Alogliptin contains Alogliptin. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is Alogliptin a controlled substance?
Alogliptin is not classified as a controlled substance by the DEA.
What is the generic name for Alogliptin?
The generic name for Alogliptin is Alogliptin. There are 9 other brand versions of Alogliptin.
What is the NDC code for Alogliptin 12.5 mg/1?
The NDC (National Drug Code) for Alogliptin 12.5 mg/1 is 45802-103, listed by Padagis Israel Pharmaceuticals Ltd.
Other Alogliptin Dosages
Other Alogliptin Brands
See all →- Nesina12.5 mg/164764-125
- Nesina25 mg/164764-250
- KAZANO12.5 mg/164764-337
- Alogliptin and Pioglitazone12.5 mg/145802-260
- Alogliptin and Pioglitazone25 mg/145802-351
- OSENI12.5 mg/164764-123
- Nesina6.25 mg/164764-625
- alogliptin and metformin hydrochloride12.5 mg/145802-169
- Alogliptin and Pioglitazone25 mg/145802-402
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)